SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-19
👔
Vaxcyte, Inc.
@PCVX_InsiderForm 4 Filing: GUGGENHIME ANDREW Sells $583,500 of $PCVX
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Vaxcyte, Inc.
Ticker: $PCVX
Transaction Value
$583,500
Price/Share: $29.18
transaction date
2026-06-18
Shares: 20,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, GUGGENHIME ANDREW, holds the title of PRESIDENT AND CFO at Vaxcyte, Inc..
On 2026-06-18, the insider transacted 20,000 shares.The shares were transacted at a weighted average price of $29.18 per share, resulting in a total market-relevant value of $583,500.
Executive Summary Summary
GUGGENHIME ANDREW (PRESIDENT AND CFO) sold $584K of $PCVX
Post-Transaction Position: 104,395 shares
SEC Accession No: 0001230724-26-000010 (CIK: 1230724)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.